Please find the upcoming e-Chalk Talk of potential interest in the biomarker and precision medicine space.
The eChalk Talk will cover the use of
small molecule biomarkers to improve patient selection and enrich responders as part of a clinical trial strategy.
Speakers will discuss:
- The challenges to achieving smaller, faster, and more effective clinical trial designs
- Limitations of using polygenic risk scores alone to predict treatment response
- The use of small molecule markers to enhance biomarker-guided patient selection
- Technologies enabling rapid identification of small molecule biomarkers of drug response
- The impact of small molecule biomarkers in clinical trials through case report examples
Registration Link below:
eChalk Talk: The Clinical Trial Conundrum: Identifying Responders vs. Non-Responders | AAPS------------------------------
Amanda Hays Ph.D.
Scientific Officer
BioAgilytix
Olathe KS
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------